Personalized total neoadjuvant therapy versus chemotherapy during the ‘wait period’ versus standard chemoradiotherapy for locally advanced rectal cancer
Sign Up to like & getrecommendations! Published in 2022 at "ANZ Journal of Surgery"
DOI: 10.1111/ans.18229
Abstract: This study aimed to compare current treatment response rates with personalized Total Neoadjuvant Therapy (pTNT), against extended chemotherapy in the ‘wait period’ (xCRT) and standard chemoradiotherapy (sCRT) with adjuvant chemotherapy for rectal cancer. read more here.
Keywords: neoadjuvant therapy; standard chemoradiotherapy; total neoadjuvant; personalized total ... See more keywords
Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus Standard Chemoradiotherapy: 5-Year Follow-Up
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.859992
Abstract: Background Human papillomavirus-positive oropharyngeal carcinoma (HPVOPC) portends a more favorable prognosis compared to environmentally related oropharynx cancer (EROPC). Patients with HPVOPC may be overtreated and endure unnecessary long-term toxicities. Methods Patients with untreated locally advanced… read more here.
Keywords: year; positive oropharyngeal; trial; cancer ... See more keywords